Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001209191-19-041757

Director sold 6,000 shares at an average $42.60 ($255,570)

  • Director acquired 6,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kurkijarvi Kalevi · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2019-07-08 Exercise or conversion : show line 1 in the form +6,000 $3.50 $21,000 34,400 D
2019-07-08 Sale : show line 2 in the form −4,600 $42.35 $194,810 29,800 D
2019-07-08 Sale : show line 3 in the form −1,400 $43.40 $60,760 28,400 D
Open-market sales · 6,000 sh · avg $42.60 · $255,570

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-07-08 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −6,000 $3.50 2021-03-15 6,000 6,000 D
Loading xslF345X03/doc4.xml…